Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Burlew

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Cardiology|February 1, 1986
Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failureS M Jafri, B S Burlew, A D Goldberg, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Effects of age on the protein binding and disposition of propranolol stereoisomersR L Lalonde, D M Tenero, B S Burlew, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderlyD M Tenero, M B Bottorff, B S Burlew, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administrationK M Sowinski, J J Lima, B S Burlew, et al.
The American Journal of Cardiology|May 1, 1987
Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathyS M Jafri, B S Burlew, A D Goldberg, et al.
Transplantation|April 27, 1995
Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipientsA O Gaber, S el-Gebely, P Sugathan, et al.
Transplantation Proceedings|February 1, 1995
Changes in cardiac function of type I diabetics following pancreas-kidney and kidney-alone transplantationA O Gaber, S el-Gebely, P Sugathan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Cardiology|February 1, 1986
Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failureS M Jafri, B S Burlew, A D Goldberg, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Effects of age on the protein binding and disposition of propranolol stereoisomersR L Lalonde, D M Tenero, B S Burlew, et al.
Journal of Cardiovascular Pharmacology|November 1, 1990
Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderlyD M Tenero, M B Bottorff, B S Burlew, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administrationK M Sowinski, J J Lima, B S Burlew, et al.
The American Journal of Cardiology|May 1, 1987
Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathyS M Jafri, B S Burlew, A D Goldberg, et al.
Transplantation|April 27, 1995
Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipientsA O Gaber, S el-Gebely, P Sugathan, et al.
Transplantation Proceedings|February 1, 1995
Changes in cardiac function of type I diabetics following pancreas-kidney and kidney-alone transplantationA O Gaber, S el-Gebely, P Sugathan, et al.
Pageof 2